CSI Laboratories’ C•RESULTS Colorectal Carcinoma Panel Mirrors Recently Published Recommendations by ASCP, CAP, AMP, and ASCO

The recent publication of recommendations for molecular biomarkers in colorectal carcinoma by several key societies including the American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO), seeks to create a general consensus for best molecular diagnostic practices in the realm of colorectal carcinoma. A hallmark of CSI Laboratories’ commitment to quality is to only perform testing that is medically necessary, which is why CSI offers a targeted C•Results Colorectal Carcinoma Panel including extended KRAS and NRAS testing, BRAF by PCR, and MMRP by IHC to assist pathologists and oncologists with treatment decisions for colorectal cancer patients. CSI Laboratories offers healthcare providers the highest quality testing standards used to optimize treatment care decisions.

C•RESULTS Colorectal Carcinoma Panel

ASCP-CAP-AMP-ASCO Recommendations for Molecular Biomarkers for the Evaluation of Colorectal Cancer